Clarient, Inc. provides the marketplace access to advanced technologies and services for the characterization, assessment and treatment of cancer, leading to accurate diagnoses by pathologists, confident treatment decisions by oncologists, and efficient ways to reduce the cost and accelerate the drug development process with the identification and development of pharmaceuticals and, ultimately better outcomes for patients.
Blog: 
Clarient, Inc. provides the marketplace access to advanced technologies and services for the characterization, assessment and treatment of cancer, leading to accurate diagnoses by pathologists, confident treatment decisions by oncologists, and efficient ways to reduce the cost and accelerate the drug development process with the identification and development of pharmaceuticals and, ultimately better outcomes for patients. 
